| Line item | 2026-01-31 FY | 2025-01-31 FY | 2024-01-31 FY | 2023-01-31 FY | 2022-01-31 FY | 2021-01-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $5.61M | $248.20K |
| Cost of Revenue | $0.00 | – | $0.00 | $3.33M | $3.55M | $136.00K |
| Gross Profit | $0.00 | – | $0.00 | -$3.33M | $2.07M | $112.20K |
| Operating Expenses | – | – | – | – | – | – |
| R&D | – | – | – | – | – | – |
| SG&A | $385.41K | $679.91K | $1.12M | $844.84K | $586.89K | $537.58K |
| Operating Income | -$385.41K | -$679.91K | -$1.12M | -$4.18M | -$1.48M | -$425.38K |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | $29.96K | $95.01K | $0.00 | -$5.38K | $217.10K | $0.00 |
| Net Income | -$415.37K | -$774.92K | -$1.12M | -$4.16M | -$1.26M | -$425.38K |
| EPS (basic) | – | – | – | – | – | – |
| EPS (diluted) | 0.0000 | 0.0000 | -0.0100 | -0.0200 | – | – |
| Shares (diluted) | $207.03M | $207.03M | $207.03M | $206.52M | – | $91.09M |